Form 424B2 MORGAN STANLEY
The information in this pricing supplement is not complete and may be changed. We may not deliver these securities until a final pricing supplement is delivered. This pricing
supplement and the accompanying prospectus supplement and prospectus do not constitute an offer to sell these securities and we are not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
Subject to... (continue reading...)
Form 8-K WinVest Acquisition Corp For: Apr 16
false
0001854463
0001854463
2024-04-16
2024-04-16
0001854463
WINV:UnitsEachConsistingOfOneShareOfCommonStockOneRedeemableWarrantAndOneRightMember
2024-04-16
2024-04-16
0001854463
WINV:CommonStockParValue0.0001PerShareMember
... (continue reading...)
Form 6-K CHUNGHWA TELECOM CO LTD For: Apr 17
1934 Act Registration No. 1-31731
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUERPURSUANT TO RULE 13a-16 OR 15d-16 OFTHE SECURITIES EXCHANGE ACT OF 1934
Dated April 17, 2024
Chunghwa Telecom Co., Ltd.
(Translation of Registrant’s Name into English)
21-3 Xinyi Road Sec. 1,
Taipei, Taiwan, 100 R.O.C.
(Address of Principal Executive Office)
(Indicate... (continue reading...)
Form 8-K ABBOTT LABORATORIES For: Apr 17
0000001800FALSENew York Stock ExchangeChicago Stock Exchange, Inc.00000018002024-01-012024-03-310000001800exch:XCHI2024-01-012024-03-310000001800exch:XNYS2024-01-012024-03-31UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D. C. 20549_______________________________________________________FORM 8-KCURRENT REPORTPursuant to Section 13 or 15(d) of theSecurities Exchange Act of 1934April 17, 2024Date of Report (Date of earliest event reported)ABBOTT LABORATORIES... (continue reading...)
More SEC Filings
View Older Stories-
Form 13F-HR Acropolis Investment For: Mar 31
-
Form 8-K PEDEVCO CORP For: Apr 17
-
Form 8-K WINDTREE THERAPEUTICS For: Apr 17
-
Form 424B3 Metals Acquisition Ltd
-
Form 6-K KB Financial Group Inc. For: Apr 17
-
Form 144 Nano Dimension Ltd. Filed by: Geddes Nicholas Campbell
-
Form 424B3 Goodness Growth Holdings
-
Form DEFA14A Goodness Growth Holdings
-
Form 8-K Goodness Growth Holdings For: Apr 12
-
Form 6-K BioLineRx Ltd. For: Apr 17
-
Form 6-K BANK OF MONTREAL /CAN/ For: Apr 16
-
Form 8-K INSPIRE VETERINARY PARTN For: Apr 16
-
Form 6-K Oatly Group AB For: Apr 17
-
Form 6-K Hafnia Ltd For: Apr 17
-
Form DEFA14A PARKS AMERICA, INC
-
Form 8-K ENTEGRIS INC For: Apr 17
-
Form 8-K TRAVELERS COMPANIES, For: Apr 17
-
Form 8-K Pluri Inc. For: Apr 15
-
Form 6-K GILAT SATELLITE NETWORKS For: Apr 17
-
Form 6-K AVINO SILVER & GOLD MINE For: Apr 17
-
Form 8-K US BANCORP \DE\ For: Apr 17
-
Form 8-K BankUnited, Inc. For: Apr 17
-
Form D Kedaara Capital Growth
-
Form 8-K Trio Petroleum Corp. For: Apr 16
-
Form DEFA14A HBT Financial, Inc.
-
Form DEF 14A HBT Financial, Inc. For: May 28
-
Form 6-K Inspira Technologies For: Apr 17
-
Form 6-K SHL TELEMEDICINE LTD For: Apr 17
-
Form 6-K XPENG INC. For: Apr 17
-
Form 8-K Sage Therapeutics, Inc. For: Apr 17
-
Form 8-K FIRST HORIZON CORP For: Apr 17
-
Form 20-F XPENG INC. For: Dec 31
-
Form 8-K IQVIA HOLDINGS INC. For: Apr 16
-
Form 6-K MILLICOM INTERNATIONAL For: Apr 17
-
Form 8-K CITIZENS FINANCIAL GROUP For: Apr 17
-
Form PRE 14A Tesla, Inc. For: Jun 13
-
Form D ME-0203 Fund I, a series
-
Form 6-K Ferrari N.V. For: Apr 17
-
Form 8-K TScan Therapeutics, Inc. For: Apr 16
-
Form 10-K New Momentum Corp. For: Dec 31
-
Form 6-K ONECONNECT FINANCIAL For: Apr 17
-
Form FWP TScan Therapeutics, Inc. Filed by: TScan Therapeutics, Inc.
-
Form 10-K THERAPEUTIC SOLUTIONS For: Dec 31
-
Form ARS CoreCard Corp For: Dec 31
-
Form 13F-HR WealthNavi Inc. For: Mar 31
-
Form 6-K Baozun Inc. For: Apr 17
-
Form 6-K GSK plc For: Apr 17
-
Form D/A Sage Partners Offshore
-
Form 8-K Research Solutions, Inc. For: Apr 15
-
Form ARS Clene Inc. For: Dec 31